Oncology practices face denial rates of 15%–20%, putting millions in potential revenue at risk. Medical necessity, prior authorization, and documentation issues can leave valuable claims unresolved.
Dr Biller RCM helps oncology practices identify denial causes, correct claim issues, manage appeals, and pursue unpaid revenue before preventable denials become long-term financial losses.
Oncology claims face complex payer requirements involving treatment authorization, medical necessity, coding, documentation, and coverage policies. Minor billing discrepancies can delay reimbursement or cause costly denials.
Payers may question whether the documented diagnosis and clinical information support the treatment or service billed.
Missing, incomplete, expired, or mismatched authorizations can cause chemotherapy, radiation, medications, and other oncology services to be denied.
Incorrect CPT, HCPCS, J-codes, modifiers, units, or diagnosis codes can create avoidable claim issues.
Missing clinical notes, treatment records, cancer staging, drug administration details, or supporting documentation can weaken a claim.
Certain oncology treatments may require additional clinical evidence or supporting references to establish coverage.
Differences in payer policies, coverage rules, and documentation requirements can make oncology claims particularly difficult to manage.
Missed filing or appeal deadlines can prevent practices from recovering otherwise collectible revenue.
Dr Biller RCM provides oncology-focused denial management to help practices address unpaid claims, correct billing issues, and recover revenue tied up in payer denials. Our team reviews each denial, determines the underlying issue, and takes the appropriate steps toward resolution.
Oncology Denial Management Services help practices address costly payer denials, strengthen appeals, recover revenue, and respond to complex oncology billing requirements.
| Key Industry Figure | What It Shows | Dr Biller RCM Response | Practice Impact |
|---|---|---|---|
| 15%–20% Denial Rate | Oncology claims can face higher denial rates than many specialties. | Identify denial causes and payer patterns. | Supports timely claim recovery. |
| $3M–$4M Revenue at Risk | Average oncology practices may lose millions annually from denied claims, with 60%+ considered avoidable. | Focus on root-cause analysis and prevention. | Helps protect collectible revenue. |
| 15%–19% RT Denials | Radiation therapy faces significantly higher inappropriate denial rates than other health services. | Review radiation claims, authorization, and documentation. | Supports stronger resolution and appeals. |
| 41%–82% IMRT Denials | Inappropriate denial rates can be particularly high for certain IMRT and cancer-specific cases. | Assess denial rationale and supporting clinical information. | Helps practices pursue complex claims. |
| 50% Medical Necessity | Medical necessity is reported as a major reason for initial coverage denials. | Review clinical support and payer criteria. | Strengthens medical-necessity appeals. |
| 31% Off-Label Denials | Off-label treatments may require supporting evidence and approved compendia references. | Review documentation and appeal requirements. | Supports evidence-based appeals. |
| 61% Prior-Authorization Appeal Success | Some prior-authorization-related denials are overturned when appealed. | Track authorization denials and manage appeals. | Creates additional recovery opportunities. |
| 46% Genetic Testing Reversals | Independent reviews have overturned a substantial share of cancer-related genetic testing denials. | Review denial decisions and supporting records. | Helps practices pursue appropriate reimbursement. |
Source: Figures are based on published industry research and may vary by payer, service, and patient population.
Dr Biller RCM follows a structured process to identify denial causes, correct claim issues, manage appeals, and help oncology practices recover unpaid revenue.
01
We review denied claims and classify them by payer, denial reason, service, and financial impact for faster follow-up and resolution.
02
Identified billing or documentation errors are addressed before the claim is resubmitted or moved into the appropriate appeal process.
03
Our team tracks submitted claims and appeals, communicates with payers, and follows up on unresolved cases.
04
Our team examines coding, authorization, eligibility, documentation, medical necessity, and payer requirements to determine why the claim was denied.
05
We compile relevant claim details and supporting documentation to prepare appeals based on the payer’s requirements and applicable deadlines.
06
Denial outcomes are analyzed to identify recurring patterns and help oncology practices address issues that may lead to future denials.
Dr Biller RCM manages oncology denials related to coding, authorization, medical necessity, documentation, coverage, and payer-specific requirements.
| Denial Type | Common Issue | Our Approach |
|---|---|---|
| Medical Necessity | Treatment questioned by payer. | Review clinical support and appeal. |
| Prior Authorization | Missing or incorrect authorization. | Verify and resolve authorization issues. |
| Coding & Modifiers | CPT, HCPCS, J-codes, or modifier errors. | Correct billing and resubmit. |
| Drug & Infusion | Drug or administration claims denied. | Review codes, units, and documentation. |
| Radiation & IMRT | Coverage or treatment concerns. | Review denial and supporting records. |
| Off-Label Treatment | Additional evidence requested. | Support claims with relevant documentation. |
| Documentation | Required records are missing. | Identify gaps and support appeals. |
| Genetic Testing | Coverage or policy-related denial. | Review claim and supporting records. |
| Timely Filing | Filing or appeal deadline missed. | Track deadlines and pursue options. |
| Eligibility & Coverage | Coverage information causes denial. | Verify payer and patient details. |
Dr Biller RCM provides Oncology Denial Management Services across diverse cancer care settings, helping practices address payer denials, documentation issues, authorization challenges, and reimbursement concerns specific to each specialty.
Our oncology billing support covers specialty-specific requirements for treatment, coding, authorization, documentation, and claims, helping cancer care providers manage denials while maintaining consistent follow-up and revenue recovery.
Dr Biller RCM provides Oncology Denial Management Services for practices nationwide, addressing payer requirements, claim issues, appeals, and revenue recovery across different healthcare markets.Our medical billing denial management support considers payer variations and state-level claim trends, helping oncology practices respond to denials with informed, consistent revenue cycle processes.
State figures represent 2024 in-network claim denial rates for HealthCare.gov marketplace insurers, not oncology-specific denial rates.
Oncology billing depends on accurate information moving between clinical documentation, coding, claims, and payer responses. Dr Biller RCM works with your existing EHR workflow to support accurate denial review and follow-up.
Our team reviews available claim, billing, and documentation data to identify issues contributing to oncology denials.
We monitor denied claims, appeal status, payer responses, and follow-up activity to keep unresolved revenue visible.
Relevant clinical and billing information can support reviews for medical necessity, authorization, coding, and documentation-related denials.
Denial trends and recovery activity provide visibility into recurring issues and areas requiring attention.
Unresolved oncology claims can keep valuable revenue tied up. Get expert support to review denials, strengthen appeals, and pursue the reimbursement your practice has earned.
Oncology revenue cycles require close attention to coding, authorization, documentation, payer requirements, and high-value claims. Dr Biller RCM combines specialized billing knowledge with consistent denial follow-up to help practices recover revenue and address recurring issues.
A closer look at your denial data can reveal payer patterns, recurring billing issues, coding errors, delayed payments, and missed revenue opportunities. By reviewing these trends, you can better understand where claims are getting delayed or denied and where improvements may be needed. Get an oncology RCM review to identify key revenue cycle challenges and understand what is affecting your practice’s financial performance.
Oncology denial management services identify, correct, appeal, and follow up on denied cancer care claims to help practices recover appropriate reimbursement.
Common causes include medical necessity concerns, authorization issues, coding errors, incomplete documentation, eligibility problems, timely filing, and payer-specific coverage requirements.
Published research reports varying denial rates across oncology services, with radiation, IMRT, medical necessity, and authorization among significant areas requiring close attention.
Yes. Our team reviews chemotherapy and infusion denials involving drug codes, administration codes, units, modifiers, authorization, documentation, and payer requirements.
Reviewing denial trends and root causes helps identify recurring issues, allowing practices to address billing, documentation, authorization, and payer-related problems.
Dr Biller RCM reviews denial patterns, identifies underlying issues, coordinates corrections and appeals, and tracks payer responses to support consistent revenue recovery.
